Erythropoietin in amyotrophic lateral sclerosis: a pilot, randomized, double-blind, placebo-controlled study of safety and tolerability.

Erythropoietin in amyotrophic lateral sclerosis: a pilot, randomized, double-blind, placebo-controlled study of safety and tolerability.

Item
http://www.wikidata.org/entity/Q50592658
Treatment for familial amyotrophic lateral sclerosis/motor neuron diseaseA comprehensive review of amyotrophic lateral sclerosisPromises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study.Supplementation of a clinical trial by historical control data: is the prospect of dynamic borrowing an illusion?Cervical spinal erythropoietin induces phrenic motor facilitation via extracellular signal-regulated protein kinase and Akt signaling.Recombinant human erythropoietin in amyotrophic lateral sclerosis: a pilot study of safety and feasibility.A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies.A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trial.Outcome measures in amyotrophic lateral sclerosis clinical trialsShortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement.Current and emerging treatments for amyotrophic lateral sclerosis.Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer's disease models.Erythropoietin in Friedreich ataxia: No effect on frataxin in a randomized controlled trial
P2860

Erythropoietin in amyotrophic lateral sclerosis: a pilot, randomized, double-blind, placebo-controlled study of safety and tolerability.

Item
http://www.wikidata.org/entity/Q50592658
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Erythropoietin in amyotrophic ...... dy of safety and tolerability.
@en
Erythropoietin in amyotrophic ...... dy of safety and tolerability.
@nl
type
label
Erythropoietin in amyotrophic ...... dy of safety and tolerability.
@en
Erythropoietin in amyotrophic ...... dy of safety and tolerability.
@nl
prefLabel
Erythropoietin in amyotrophic ...... dy of safety and tolerability.
@en
Erythropoietin in amyotrophic ...... dy of safety and tolerability.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Erythropoietin in amyotrophic ...... dy of safety and tolerability.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921